***Background.*** In March 2014, CDC reported a national decrease in central line-associated bloodstream infections (CLABSIs) in ICU patients. Similar reductions have not yet been reported in non-ICU settings**.** At Boston Medical Center (BMC), sickle cell (SS) and hemodialysis (HD) patients with unique medical, socio-economic, and behavioral challenges are at high risk of developing CLABSIs in non-ICU settings.

***Methods.*** A multidisciplinary team was formed to identify gaps in existing data and practice using an A3 Process Mapping tool. The following 6 improvement opportunities were identified: utilize electronic information systems to facilitate measurement of central line (CL) days and CLABSI rates on all non-ICU wards; identify best practices for care of SS and HD patients; revise staff communication policies; promote the use of a CL order set; monitor staff compliance with CL care protocols; and develop a patient education brochure describing risks and care of CL. Changes were implemented in March 2012. Non-ICU CLABSI rates and CL utilization ratios were measured before and after the interventions. Rates of CLABSI among HD and sickle cell patients were compared. A two-sample z-test was used to measure statistical significance.

***Results.*** The CLABSI rate for all non-ICU patients decreased from 0.60/1,000 CL days in 2012 to 0.42/1,000 CL days in 2013 (p = 0.43). The CL utilization ratio in non-ICU patients decreased from 0.30 in 2012 to 0.21 in 2013 (p \< 0.001). Non-ICU CLABSIs accounted for 83% (15/18) of all CLABSIs at BMC during 2012, and 43.7% (7/16) in 2013 (p = 0.016). One third of the non-ICU CLABSIs in 2012 occurred in HD and sickle cell patients but no CLABSIs occurred in these groups in 2013 (p = 0.08).

***Conclusion.*** Involving key stakeholders to define, document, analyze, prioritize, recommend, and implement solutions resulted in a reduction in the rate of CLABSI, improvement in patient care, and reduction in cost. Hospital-wide dissemination of compliance rates and increased education has also contributed to a decline in rates. Efforts continue to improve compliance with use of the central line order set.
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